Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 0.729
-4.07 %
$ 21 M
Market Cap
-0.81
P/E
Price Target
Average
30.32%
Revenue Forecast
Estimate
377.74%
EBIT
Estimate
--80.22%
Net Income
Estimate
44.90%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Cyclo Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for CYTH of $0.95 , with forecasts ranging from
a
low of
$0.95 to a high of $0.95 .
CYTH Lowest Price Target
Wall Street Target
0.95 USD
30.32%
CYTH Average Price Target
Wall Street Target
0.95 USD
30.32%
CYTH Highest Price Target
Wall Street Target
0.95 USD
30.32%
REVENUE FORECAST
Revenue Forecast Chart CYTH
EBIT FORECAST
EBIT Forecast Chart CYTH
NET INCOME FORECAST
Net Income Chart CYTH